Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PHGE.WS BIOMX INC C/WTS 16/10/2024 (TO PUR COM) > Detailed Quotes

PHGE.WS BIOMX INC C/WTS 16/10/2024 (TO PUR COM)

Watchlist
0.0170.0000.00%
Close  02/03 16:00 ET
High
0.019
Open
0.015
Turnover
179.00
Low
0.012
Pre Close
0.017
Volume
10.96K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.215
Shares
0
P/E(Static)
0.00
52wk Low
0.007
Float Cap
0
Bid/Ask %
95.03%
Historical High
0.518
Shs Float
0
Volume Ratio
0.98
Historical Low
0.007
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
43.37%
Avg Price
0.016
Lot Size
1
Float Cap
0
Bid/Ask %
95.03%
Historical High
0.518
Shs Float
0
Volume Ratio
0.98
Historical Low
0.007
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
43.37%
Avg Price
0.016
Lot Size
1
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

No Data

Company Overview More
BiomX, Inc. operates as a clinical-stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. The firm discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
CEO： Mr. Jonathan Solomon
Market： AMEX
Listing Date： 12/14/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist